Perfil
Patrick Loustau is President, Chief Executive Officer & Director at Granite Bio AG since 2025.
Formerly, Mr. Loustau was Senior Vice President-Global Commercialization at Bristol Myers Squibb Co. in 2014, President at Zafgen, Inc. from 2014 to 2016, and Senior VP-Global Marketing & Medical Affairs at Novo Nordisk A until 2010.
Education includes graduate studies at Université de Paris XI Paris Sud.
Cargos activos de Patrick Loustau
| Empresas | Cargo | Inicio |
|---|---|---|
Granite Bio AG
Granite Bio AG BiotechnologyHealth Technology Operates as a biotechnology company which develops therapeutic antibodies | Director Ejecutivo | 01/02/2025 |
Antiguos cargos conocidos de Patrick Loustau.
| Empresas | Cargo | Fin |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Presidente | 19/07/2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/04/2014 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/07/2010 |
Formación de Patrick Loustau.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Zafgen, Inc.
Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Université de Paris XI Paris Sud
Université de Paris XI Paris Sud Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Granite Bio AG
Granite Bio AG BiotechnologyHealth Technology Operates as a biotechnology company which develops therapeutic antibodies | Health Technology |
- Bolsa de valores
- Insiders
- Patrick Loustau
















